6
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

DNA synthesis in pulmonary alveolar macrophages and type II cells: Effects of ozone exposure and treatment with α‐difluoromethylornithine

, , , , &
Pages 15-26 | Received 05 Jul 1986, Accepted 25 Oct 1986, Published online: 15 Oct 2009
 

Abstract

An increase in the number of pulmonary alveolar macrophages (AM) can be induced by a number of toxic insults to the lung, including ozone, an important photochemical oxidant air pollutant. This increase could arise from an influx of monocytes from the vascular or interstitial compartments, or from proliferation of AM in situ. While proliferation of alveolar type II cells after oxidant exposure has been well documented, it is not clear whether AM are also capable of this response. Rats were exposed to air or to 0.12, 0.25, or 0.50 ppm ozone for 1, 2, 3, 7, or 14 d, 20 hid. The labeling index in both AM and type II cells increased about 10‐fold after 2 d of exposure to 0.25 and 0.50 ppm of ozone, but returned to control levels by the end of 1 wk of exposure. These changes closely paralleled the temporal and dose‐response characteristics of changes in total lung DNA synthesis. α‐Difluoromethylornithine (DFMO) administered to rats during a 2‐d exposure to 0.50 ppm ozone did not inhibit the ozone‐induced increase in labeling index in AM or type II cells, although evidence of inhibition of lung ornithine decarboxylase activity was obtained, and the ozone‐induced increase in total lung DNA synthesis was inhibited by 23%. These results suggest that, like type II cells, AM are capable of entering the cell cycle and synthesizing new DNA in situ in response to short‐term exposure to environmentally relevant doses of ozone, and that the ozone‐induced stimulation of DNA synthesis in these cell types was refractory to inhibition by DFMO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.